Received Jun 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | LA |
2 quarter sized, red, welts on the left side of lower neck where it meets shoulder/ felt the second one; This non-serious case was reported by a consumer via call center representative and described the occurrence of welts in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 02-JUN-2025, the patient received the 2nd dose of Shingrix (left arm). On 03-JUN-2025, 1 days after receiving Shingrix, the patient experienced welts (Verbatim: 2 quarter sized, red, welts on the left side of lower neck where it meets shoulder/ felt the second one). The outcome of the welts was not resolved. It was unknown if the reporter considered the welts to be related to Shingrix. It was unknown if the company considered the welts to be related to Shingrix. Additional Information: GSK Receipt Date: 04-JUN-2025 A female patient reported she received second dose of Shingrix vaccine in the left arm and 24 hours later she noticed the first welt and this morning (48 hours after vaccine) felt the second one. The reporter is experiencing 2 quarter sized, red, welts on the left side of lower neck where it meets shoulder. She consulted with her pharmacist as her HCP is on vacation. The medical advice disclaimer was provided and spoke per PI, offered PI and Shingrix website and the reporter was referred to Health Care Professional.